| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |